 |
 |
 |
Basal Cell Carcinoma - Skin Cancer
Skin cancer is the most common carcinoma in man today. Currently the treatment of choice for this type of skin cancer is surgical in the majority of cases. Development of an effective non-surgical mode of treatment is important for several reasons. Since these tumors often occur in functionally and cosmetically critical areas, maximal tissue preservation is essential. General clinical considerations also make non-surgical removal of these tumors desirable in the elderly, in debilitated patients, and in patients receiving anticoagulants.
Controlled localized heating offers the advantage of a non-surgical mode of treatment with minimal trauma.
 |
 |
 |
| Before | Before - Detail View | After |
TTI performed a Clinical Trial to evaluate the safety and efficacy of the ThermoMed™ Model 1.8 device in the treatment of basal cell carcinoma. The following statistics are from that study.
Patients rated treatment comfort, convenience, and side effects on a scale of 1-10, with 10 being the most favorable.
| Category | Average Patient Rating |
|---|---|
| Comfort | 8.35 |
| Convenience | 8.97 |
| Side Effects | 9.02 |
Patient rated TTI's treatment to other treatment(s) that they had previously received.
| Treatment | Patient Survey Results |
|---|---|
| 5-FU | 100.00% patients said TTI better or equal |
| Cryotherapy | 95.24% patients said TTI better or equal |
| Radiation | 100.00% patients said TTI better or equal |
| Surgery | 82.14% patients said TTI better or equal |
| Other | 100.00% patients said TTI better or equal |
Copyright © . Thermosurgery Technologies, Inc. All Rights Reserved.